These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Comparative study of several preparations in different models of cerebral hypoxia]. Ivanova IA; Bobkov IuG Biull Eksp Biol Med; 1984 Nov; 98(11):567-70. PubMed ID: 6509174 [TBL] [Abstract][Full Text] [Related]
4. [Effects of ethomersol on cerebrovascular blood circulation and oxygen metabolism of the brain in acute transient ischemia and recirculation]. Plotnikova TM; Kulakova ZV; Plotnikov MB Biull Eksp Biol Med; 1991 Apr; 111(4):386-8. PubMed ID: 1893143 [TBL] [Abstract][Full Text] [Related]
5. [The effect of ethomersol on local cerebral blood flow and edema of the brain tissue in chronic ischemia]. Vaizova OE; Plotnikova TM; Plotnikov MB Eksp Klin Farmakol; 1994; 57(1):25-7. PubMed ID: 8142857 [TBL] [Abstract][Full Text] [Related]
6. [Cerebokrast as a corrector of postischemic phenomena in acute transient cerebral ischemia]. Bazhenova TG; Plotnikov MB; Plotnikova TM; Saratikov AS Biull Eksp Biol Med; 1992 Oct; 114(10):378-80. PubMed ID: 1288692 [TBL] [Abstract][Full Text] [Related]
7. Cavinton, a new cerebral vasodilator. Solti F Ther Hung; 1979; 27(1):15-6. PubMed ID: 494137 [No Abstract] [Full Text] [Related]
8. [Cavinton in the therapy of cerebrovascular disorders]. Kalvach P; Bauer J; Ságová V Cesk Neurol Neurochir; 1982 Nov; 45(6):380-5. PubMed ID: 7151202 [No Abstract] [Full Text] [Related]
9. [The mechanisms of the ethomersol correction of postischemic hypoperfusion]. Plotnikova TM; Kulakova ZV; Smol'iakova VI; Plotnikov MB Eksp Klin Farmakol; 1992; 55(4):11-3. PubMed ID: 1458175 [TBL] [Abstract][Full Text] [Related]
10. [Antihypoxic action of orotic acid]. Nikolova M; Nikolov R Eksp Med Morfol; 1981; 20(3):171-6. PubMed ID: 7308124 [TBL] [Abstract][Full Text] [Related]
11. Cerebral metabolic, hemodynamic and antihypoxic properties of l-eburnamonine. Linée P; Lacroix P; Le Polles JB; Aurousseau M; Boulu R; Van den Driessche J; Albert O Eur Neurol; 1978; 17 Suppl 1():113-20. PubMed ID: 753626 [TBL] [Abstract][Full Text] [Related]
12. [The comparative efficacy of emoxipine and sodium oxybutyrate in experimental myocardial ischemia]. Afanas'ev SA; Alekseeva ED; Bardamova IB; Bogomaz SA Eksp Klin Farmakol; 1994; 57(4):24-6. PubMed ID: 7950776 [TBL] [Abstract][Full Text] [Related]
14. The pharmacological basis for the treatment of brain ischemia and hypoxia. Wauquier A; Ashton D Prog Clin Biol Res; 1988; 264():169-79. PubMed ID: 3289021 [No Abstract] [Full Text] [Related]
15. [Methodological approaches to the search for pharmacological agents effective in cerebral hypoxia and ischemia]. Bobkov IuG; Ivanova IA Patol Fiziol Eksp Ter; 1987; (6):13-9. PubMed ID: 3444668 [No Abstract] [Full Text] [Related]
16. [Extension of the concept of post-anoxic cerebral protection to 4-hydroxybutyrate]. Boulard G; Guérin J; Scontrini G; Desplat A; Sabathié M Agressologie; 1982; 23(C):17-20. PubMed ID: 7125087 [No Abstract] [Full Text] [Related]
17. [An effect of vinpocetine (cavinton) on endothelium function in patients with chronic cerebral ischemia]. Vaizova OE; Vengerovskiĭ AI; Alifirova VM Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():46-50. PubMed ID: 18196635 [TBL] [Abstract][Full Text] [Related]
18. [Effects of Cavinton on the pathological changes in ischemic brain changes starting as an acute disease]. Bałuka-Horecka M Przegl Lek; 1982; 39(4):325-8. PubMed ID: 7100509 [No Abstract] [Full Text] [Related]
20. [Pathogenetically based correction of cerebral circulatory hypoxia in the acute period of experimental intracerebral hemorrhage]. Saratikov AS; Plotnikov MB Vestn Akad Med Nauk SSSR; 1984; (11):68-71. PubMed ID: 6528729 [No Abstract] [Full Text] [Related] [Next] [New Search]